IBS as a diverse disease. A comprehensive review
DOI:
https://doi.org/10.12775/JEHS.2025.77.57134Keywords
IBS, diet, treatment, psychologyAbstract
Introduction: Irritable Bowel Syndrome is one of the most popular diseases among the gastrointestinal difficulties. The main problem is lower quality of life because of troublesome symptoms of the disease.
Aim of the study: This review seeks to consolidate the current understanding of IBS, emphasizing the prevalence of this condition and the persistent challenges in achieving a definitive understanding, even after decades of research. The primary objective is to highlight contemporary approaches to patient care, revisiting both pharmacological and non-pharmacological treatment strategies.
Materials and methods: The analysis is based on a thorough review of peer-reviewed literature published between 2020 and 2025, ensuring the inclusion of the most up-to-date insights. Knowledge was sourced from PubMed using the advanced search with terms „irritable bowel syndrome” with „or” and „IBS”, ultimately returning 1,228 results.
Results and conclusion: The findings underscore the necessity of a multidisciplinary approach involving a team of specialists to provide comprehensive care. Additionally, a crucial factor is the patient's diet and overall well-being, which play a pivotal role in determining the progression and course of the condition. Furthermore, a clear conclusion has been established that, the psychological dimension—integral to both the disease and its management—emerges as a critical factor that warrants careful consideration and should not be underestimated.
References
Altomare, Annamaria, Claudia Di Rosa, Elena Imperia, Sara Emerenziani, Michele Cicala, and Michele Pier Luca Guarino. 2021. “Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.” Nutrients 13 (5): 1506. https://doi.org/10.3390/nu13051506.
Anand, Khushi, and Mahalaqua Nazli Khatib. 2024. “Causative Factors, Clinical Manifestations, and Therapeutic Strategies for Irritable Bowel Syndrome.” Cureus 16 (4): e58728. https://doi.org/10.7759/cureus.58728.
Aziz, Muhammad Nazirul Mubin, Jaya Kumar, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, and Norfilza M. Mokhtar. 2021. “Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain.” Nutrients 13 (9): 3061. https://doi.org/10.3390/nu13093061.
Banerjee, Arka, Sujit Sarkhel, Gopal Krishna Dhali, Imon Paul, and Anamika Das. 2024. “A Follow-up Study of Anxiety and Depressive Symptoms in Irritable Bowel Syndrome.” Indian Journal of Psychiatry 66 (2): 142–47. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_732_23.
Bellini, Massimo, Sara Tonarelli, Attila G. Nagy, Andrea Pancetti, Francesco Costa, Angelo Ricchiuti, Nicola de Bortoli, Marta Mosca, Santino Marchi, and Alessandra Rossi. 2020. “Low FODMAP Diet: Evidence, Doubts, and Hopes.” Nutrients 12 (1): 148. https://doi.org/10.3390/nu12010148.
Bertin, Luisa, Miriana Zanconato, Martina Crepaldi, Giovanni Marasco, Cesare Cremon, Giovanni Barbara, Brigida Barberio, Fabiana Zingone, and Edoardo Vincenzo Savarino. 2024. “The Role of the FODMAP Diet in IBS.” Nutrients 16 (3): 370. https://doi.org/10.3390/nu16030370.
Berumen, Antonio, Adam L. Edwinson, and Madhusudan Grover. 2021. “Post-Infection Irritable Bowel Syndrome.” Gastroenterology Clinics of North America 50 (2): 445–61. https://doi.org/10.1016/j.gtc.2021.02.007.
Black, Christopher J., and Alexander C. Ford. 2020. “Global Burden of Irritable Bowel Syndrome: Trends, Predictions and Risk Factors.” Nature Reviews. Gastroenterology & Hepatology 17 (8): 473–86. https://doi.org/10.1038/s41575-020-0286-8.
Black, Christopher J., Heidi M. Staudacher, and Alexander C. Ford. 2022. “Efficacy of a Low FODMAP Diet in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis.” Gut 71 (6): 1117–26. https://doi.org/10.1136/gutjnl-2021-325214.
Camilleri, Michael, and Guy Boeckxstaens. 2023. “Irritable Bowel Syndrome: Treatment Based on Pathophysiology and Biomarkers.” Gut 72 (3): 590–99. https://doi.org/10.1136/gutjnl-2022-328515.
Castro Tejera, Valeria, Lena Öhman, Lars Aabakken, Bengt Fellström, Trygve Hausken, Øistein Hovde, Johann P. Hreinsson, et al. 2022. “Randomised Clinical Trial and Meta-Analysis: Mesalazine Treatment in Irritable Bowel Syndrome—Effects on Gastrointestinal Symptoms and Rectal Biomarkers of Immune Activity.” Alimentary Pharmacology & Therapeutics 56 (6): 968–79. https://doi.org/10.1111/apt.17182.
Cheng, Kathleen, Christina Lee, Ramune Garniene, Howard Cabral, and Horst Christian Weber. 2024. “Epidemiology of Irritable Bowel Syndrome in a Large Academic Safety-Net Hospital.” Journal of Clinical Medicine 13 (5): 1314. https://doi.org/10.3390/jcm13051314.
Chiarioni, Giuseppe, Stefan Lucian Popa, Abdulrahman Ismaiel, Cristina Pop, Dinu Iuliu Dumitrascu, Vlad Dumitru Brata, Traian Adrian Duse, Victor Incze, and Teodora Surdea-Blaga. 2023. “The Effect of Polyphenols, Minerals, Fibers, and Fruits on Irritable Bowel Syndrome: A Systematic Review.” Nutrients 15 (18): 4070. https://doi.org/10.3390/nu15184070.
Dai, Cong, Yu-Hong Huang, and Min Jiang. 2024. “Fecal Microbiota Transplantation for Irritable Bowel Syndrome: Current Evidence and Perspectives.” World Journal of Gastroenterology 30 (16): 2179–83. https://doi.org/10.3748/wjg.v30.i16.2179.
Dimidi, Eirini, and Kevin Whelan. 2020. “Food Supplements and Diet as Treatment Options in Irritable Bowel Syndrome.” Neurogastroenterology and Motility 32 (8): e13951. https://doi.org/10.1111/nmo.13951.
D’Silva, Adrijana, Deborah A. Marshall, Jeff K. Vallance, Yasmin Nasser, Vidya Rajagopalan, Jessie H. Szostakiwskyj, and Maitreyi Raman. 2023. “Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial.” The American Journal of Gastroenterology 118 (2): 329–37. https://doi.org/10.14309/ajg.0000000000002052.
El-Salhy, Magdy, Jan Gunnar Hatlebakk, and Trygve Hausken. 2019. “Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones.” Nutrients 11 (8): 1824. https://doi.org/10.3390/nu11081824.
Fadgyas Stanculete, Mihaela, Abdulrahman Ismaiel, Stefan-Lucian Popa, and Octavia Oana Capatina. 2023. “Irritable Bowel Syndrome and Resilience.” Journal of Clinical Medicine 12 (13): 4220. https://doi.org/10.3390/jcm12134220.
Ford, Alexander C., Alexandra Wright-Hughes, Sarah L. Alderson, Pei-Loo Ow, Matthew J. Ridd, Robbie Foy, Gina Bianco, et al. 2023. “Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in Primary Care (ATLANTIS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial.” The Lancet 402 (10414): 1773–85. https://doi.org/10.1016/S0140-6736(23)01523-4.
Francavilla, Ruggiero, Maria Piccolo, Antonio Francavilla, Lorenzo Polimeno, Francesco Semeraro, Fernanda Cristofori, Stefania Castellaneta, et al. 2019. “Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-Type Symptoms: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.” Journal of Clinical Gastroenterology 53 (3): e117–25. https://doi.org/10.1097/MCG.0000000000001023.
Galica, Adelina Nicoleta, Reitano Galica, and Dan Lucian Dumitrașcu. 2022. “Diet, Fibers, and Probiotics for Irritable Bowel Syndrome.” Journal of Medicine and Life 15 (2): 174–79. https://doi.org/10.25122/jml-2022-0028.
Goodoory, Vivek C., Ashok K. Tuteja, Christopher J. Black, and Alexander C. Ford. 2024. “Systematic Review and Meta-Analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome.” Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 22 (2): 243-251.e5. https://doi.org/10.1016/j.cgh.2023.02.014.
Grover, Madhusudan, Bhanu Prakash Kolla, Rahul Pamarthy, Meghna P. Mansukhani, Margaret Breen-Lyles, Jian-Ping He, and Kathleen R. Merikangas. 2021. “Psychological, Physical, and Sleep Comorbidities and Functional Impairment in Irritable Bowel Syndrome: Results from a National Survey of U.S. Adults.” PloS One 16 (1): e0245323. https://doi.org/10.1371/journal.pone.0245323.
Herekar, Anam, Dhanush Shimoga, Asad Jehangir, Dariush Shahsavari, Yun Yan, Tennekoon Buddhika Karunaratne, and Amol Sharma. 2023. “Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management.” Clinical and Experimental Gastroenterology 16 (June):79–85. https://doi.org/10.2147/CEG.S384251.
Hetterich, Larissa, and Andreas Stengel. 2020. “Psychotherapeutic Interventions in Irritable Bowel Syndrome.” Frontiers in Psychiatry 11:286. https://doi.org/10.3389/fpsyt.2020.00286.
Hung, Tsung-Hsing, Chih-Ying Wang, and Hsing-Feng Lee. 2023. “Update in Diagnosis and Management of Irritable Bowel Syndrome.” Tzu Chi Medical Journal 35 (4): 306–11. https://doi.org/10.4103/tcmj.tcmj_104_23.
Jafari, Sattar, Arezoo Atmani, Sepehr Gohari, and Ehsan Seifi. 2024. “The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea Domination: A Randomized Controlled Trial.” Middle East Journal of Digestive Diseases 16 (3): 178–84. https://doi.org/10.34172/mejdd.2024.386.
Jia, Wenhan, Hong Liang, Lining Wang, Ming Sun, Xili Xie, Jie Gao, Linxian Li, Xiao Tang, and Yanan Ma. 2022. “Associations between Abnormal Eating Styles and Irritable Bowel Syndrome: A Cross-Sectional Study among Medical School Students.” Nutrients 14 (14): 2828. https://doi.org/10.3390/nu14142828.
Lacy, Brian E., Mark Pimentel, Darren M. Brenner, William D. Chey, Laurie A. Keefer, Millie D. Long, and Baha Moshiree. 2021. “ACG Clinical Guideline: Management of Irritable Bowel Syndrome.” The American Journal of Gastroenterology 116 (1): 17–44. https://doi.org/10.14309/ajg.0000000000001036.
Lembo, Anthony J. 2023. “Understanding the Current Approaches in the Management of IBS-C: A Case Study.” Gastroenterology & Hepatology 19 (6): 328–35.
Lopes, Carolina Marques, Cristina Sofia de Jesus Monteiro, Ana Paula Duarte, and Jorge Luiz dos Santos. 2024. “Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome—A Narrative Review.” Journal of Clinical Medicine 13 (21): 6337. https://doi.org/10.3390/jcm13216337.
“Low-Dose Tricyclic Antidepressants for Irritable Bowel Syndrome: Definitive Evidence of Benefit from ATLANTIS.” n.d. American College of Gastroenterology. Accessed December 3, 2024. https://gi.org/journals-publications/ebgi/schoenfeld_dec2023/.
Marasco, Giovanni, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, and Giovanni Barbara. 2024. “Journal of Clinical Gastroenterology Lectureship Dubai 2022: Management of Irritable Bowel Syndrome With Diarrhea.” Journal of Clinical Gastroenterology 58 (3): 221. https://doi.org/10.1097/MCG.0000000000001964.
Mårild, Karl, Jonas Söderling, Benjamin Lebwohl, Peter H. R. Green, Hans Törnblom, Magnus Simrén, Kyle Staller, Ola Olén, and Jonas F. Ludvigsson. 2024. “Association Between Celiac Disease and Irritable Bowel Syndrome: A Nationwide Cohort Study.” Clinical Gastroenterology and Hepatology 22 (7): 1404-1415.e20. https://doi.org/10.1016/j.cgh.2024.01.048.
Masuy, Imke, Jasper Pannemans, and Jan Tack. 2020. “Irritable Bowel Syndrome: Diagnosis and Management.” Minerva Gastroenterologica E Dietologica 66 (2): 136–50. https://doi.org/10.23736/S1121-421X.19.02640-0.
Mayer, Emeran A., Hyo Jin Ryu, and Ravi R. Bhatt. 2023. “The Neurobiology of Irritable Bowel Syndrome.” Molecular Psychiatry 28 (4): 1451–65. https://doi.org/10.1038/s41380-023-01972-w.
Nelkowska, Dominika Dorota. 2020. “Treating Irritable Bowel Syndrome through an Interdisciplinary Approach.” Annals of Gastroenterology 33 (1): 1–8. https://doi.org/10.20524/aog.2019.0441.
Pak, Anton, Madeline O’Grady, Gerald Holtmann, Ayesha Shah, and Haitham Tuffaha. 2024. “Economic Evaluations of Non-Pharmacological Interventions for Treating Disorders of Gut-Brain Interaction: A Scoping Review.” PharmacoEconomics, November. https://doi.org/10.1007/s40273-024-01455-y.
Pedersen, Natalia, Dorit Vedel Ankersen, Maria Felding, Henrik Wachmann, Zsuzsanna Végh, Line Molzen, Johan Burisch, Jens Rikardt Andersen, and Pia Munkholm. 2017. “Low-FODMAP Diet Reduces Irritable Bowel Symptoms in Patients with Inflammatory Bowel Disease.” World Journal of Gastroenterology 23 (18): 3356–66. https://doi.org/10.3748/wjg.v23.i18.3356.
“Recent Advances in the Treatment of Irritable Bowel Syndrome.” n.d. Accessed December 3, 2024. https://doi.org/10.20452/pamw.16067.
Sahi, Nidhi, Rosalee Nguyen, Preeti Patel, and Cynthia Santos. 2024. “Loperamide.” In StatPearls. Treasure Island (FL): StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK557885/.
Sebastián Domingo, Juan J. 2022. “Irritable Bowel Syndrome.” Medicina Clinica 158 (2): 76–81. https://doi.org/10.1016/j.medcli.2021.04.029.
Shah, Eric D., Brian E. Lacy, William D. Chey, Lin Chang, and Darren M. Brenner. 2021. “Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.” The American Journal of Gastroenterology 116 (8): 1601–11. https://doi.org/10.14309/ajg.0000000000001313.
Singh, Prashant, Gregory S. Sayuk, David P. Rosenbaum, Susan Edelstein, Kenji Kozuka, and Lin Chang. 2024. “An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation.” Clinical and Experimental Gastroenterology 17 (April):87–96. https://doi.org/10.2147/CEG.S454526.
Staudacher, Heidi M., Christopher J. Black, Scott B. Teasdale, Antonina Mikocka-Walus, and Laurie Keefer. 2023. “Irritable Bowel Syndrome and Mental Health Comorbidity — Approach to Multidisciplinary Management.” Nature Reviews Gastroenterology & Hepatology 20 (9): 582–96. https://doi.org/10.1038/s41575-023-00794-z.
Staudacher, Heidi M., Frances S. E. Ralph, Peter M. Irving, Kevin Whelan, and Miranda C. E. Lomer. 2020. “Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.” Journal of the Academy of Nutrition and Dietetics 120 (4): 535–47. https://doi.org/10.1016/j.jand.2019.01.017.
Staudacher, Heidi M., and Kevin Whelan. 2017. “The Low FODMAP Diet: Recent Advances in Understanding Its Mechanisms and Efficacy in IBS.” Gut 66 (8): 1517–27. https://doi.org/10.1136/gutjnl-2017-313750.
Subramanian, Lakshmimathy, Helen Coo, Alanna Jane, Jennifer A. Flemming, Amy Acker, Benjamin Hoggan, Rebecca Griffiths, Anupam Sehgal, and Daniel Mulder. 2024. “Celiac Disease and Inflammatory Bowel Disease Are Associated With Increased Risk of Eating Disorders: An Ontario Health Administrative Database Study.” Clinical and Translational Gastroenterology 15 (5): e00700. https://doi.org/10.14309/ctg.0000000000000700.
Tang, Bin-Bin, Cheng-Xia Su, Na Wen, Qian Zhang, Jian-Hui Chen, Bin-Bin Liu, Yi-Qing Wang, Chao-Qun Huang, and Yun-Lian Hu. 2024. “FMT and TCM to Treat Diarrhoeal Irritable Bowel Syndrome with Induced Spleen Deficiency Syndrome- Microbiomic and Metabolomic Insights.” BMC Microbiology 24 (1): 433. https://doi.org/10.1186/s12866-024-03592-y.
Tarar, Zahid Ijaz, Umer Farooq, Ahmad Nawaz, Mustafa Gandhi, Yezaz A. Ghouri, Asmeen Bhatt, and Brooks D. Cash. 2023. “Prevalence of Fibromyalgia and Chronic Fatigue Syndrome among Individuals with Irritable Bowel Syndrome: An Analysis of United States National Inpatient Sample Database.” Biomedicines 11 (10): 2594. https://doi.org/10.3390/biomedicines11102594.
Tarar, Zahid Ijaz, Umer Farooq, Yousaf Zafar, Mustafa Gandhi, Samina Raza, Faisal Kamal, Moosa F. Tarar, and Yezaz A. Ghouri. 2023. “Burden of Anxiety and Depression among Hospitalized Patients with Irritable Bowel Syndrome: A Nationwide Analysis.” Irish Journal of Medical Science (1971 -) 192 (5): 2159–66. https://doi.org/10.1007/s11845-022-03258-6.
Tetali, Bhavana, and Suraj Suresh. 2024. “Management of Irritable Bowel Syndrome: A Narrative Review.” Translational Gastroenterology and Hepatology 9 (0). https://doi.org/10.21037/tgh-23-96.
Valencia, Carla, Hameeda Fatima, Ijeoma Nwankwo, Mahvish Anam, Shrinkhala Maharjan, Zainab Amjad, Abdelrahman Abaza, et al. 2022. “A Correlation Between the Pathogenic Processes of Fibromyalgia and Irritable Bowel Syndrome in the Middle-Aged Population: A Systematic Review.” Cureus 14 (10). https://doi.org/10.7759/cureus.29923.
Varjú, Péter, Nelli Farkas, Péter Hegyi, András Garami, Imre Szabó, Anita Illés, Margit Solymár, et al. 2017. “Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols (FODMAP) Diet Improves Symptoms in Adults Suffering from Irritable Bowel Syndrome (IBS) Compared to Standard IBS Diet: A Meta-Analysis of Clinical Studies.” PloS One 12 (8): e0182942. https://doi.org/10.1371/journal.pone.0182942.
Vasant, Dipesh H., Peter A. Paine, Christopher J. Black, Lesley A. Houghton, Hazel A. Everitt, Maura Corsetti, Anurag Agrawal, et al. 2021. “British Society of Gastroenterology Guidelines on the Management of Irritable Bowel Syndrome.” Gut 70 (7): 1214–40. https://doi.org/10.1136/gutjnl-2021-324598.
Vijayvargiya, Priya, Margaret Breen-Lyles, Sara Linker Nord, Daniel Maselli, Irene Busciglio, Ramesh Boinpally, Anna Muslin, Timothy J. Carrothers, and Michael Camilleri. 2022. “Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study.” Digestive Diseases and Sciences 67 (8): 3911–21. https://doi.org/10.1007/s10620-022-07379-x.
Wang, Kexin, Huan Liu, Jingjing Liu, Liyuan Han, Zheng Kang, Libo Liang, Shengchao Jiang, et al. 2022. “Factors Related to Irritable Bowel Syndrome and Differences among Subtypes: A Cross-Sectional Study in the UK Biobank.” Frontiers in Pharmacology 13:905564. https://doi.org/10.3389/fphar.2022.905564.
Wang, Weiwei, Mengying Wang, Hexiang Peng, Jie Huang, and Tao Wu. 2024. “Association of Major Depressive Disorder and Increased Risk of Irritable Bowel Syndrome: A Population-Based Cohort Study and a Two-Sample Mendelian Randomization Study in the UK Biobank.” Journal of Affective Disorders 345 (January):419–26. https://doi.org/10.1016/j.jad.2023.10.111.
Wang, Yen-Po, Bing Zhang, Hohui E. Wang, Ya-Mei Bai, Shih-Jen Tsai, Tzeng-Ji Chen, and Mu-Hong Chen. 2023. “Risk of Attempted Suicide Among Patients With IBD: A Nationwide Longitudinal Follow-up Study.” Diseases of the Colon & Rectum 66 (9): e938. https://doi.org/10.1097/DCR.0000000000002705.
Wang, Yi-Nuo, Li-Ying Zhou, Yu-Hong Huang, Min Jiang, and Cong Dai. 2024. “The Incidence and Predisposing Factors for Irritable Bowel Syndrome Following COVID-19: A Systematic Review and Meta-Analysis.” European Journal of Gastroenterology & Hepatology 36 (2): 168–76. https://doi.org/10.1097/MEG.0000000000002688.
Wright-Hughes, Alexandra, Alexander C. Ford, Sarah L. Alderson, Pei Loo Ow, Matthew J. Ridd, Robbie Foy, Felicity L. Bishop, et al. 2024. “Low-Dose Titrated Amitriptyline as Second-Line Treatment for Adults with Irritable Bowel Syndrome in Primary Care: The ATLANTIS RCT.” Health Technology Assessment 28 (66): 1–161. https://doi.org/10.3310/BFCR7986.
Xiong, Qin, Fuyou Tang, Yilin Li, Fengjiao Xie, Lei Yuan, Chengjiao Yao, Ruike Wu, Juan Wang, Qiuxiang Wang, and Peimin Feng. 2022. “Association of Inflammatory Bowel Disease with Suicidal Ideation, Suicide Attempts, and Suicide: A Systematic Review and Meta-Analysis.” Journal of Psychosomatic Research 160 (September):110983. https://doi.org/10.1016/j.jpsychores.2022.110983.
Zeeshan, Muhammad Hamayl, Naga Praneeth Vakkalagadda, Gummadi Sai Sree, Krishna Kishore Anne, Sunita Devi, Om Parkash, Shaikh Basiq Ul Fawwad, Syed Muhammad Waqar Haider, Hassan Mumtaz, and Mohammad Hasan. 2022. “Irritable Bowel Syndrome in Adults: Prevalence and Risk Factors.” Annals of Medicine and Surgery (2012) 81 (September):104408. https://doi.org/10.1016/j.amsu.2022.104408.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Adrianna Dylik, Weronika Gryczyńska, Mikołaj Musiał, Łukasz Krawczak, Hanna Gulaczyk, Jan Spychalski, Mikołaj Kaczmarek, Wiktoria Grochowska, Maria Spychalska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 34
Number of citations: 0
